Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

CMPX Compass Therapeutics Inc

1,50

0,01 (0,67%)

26 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Compass Therapeutics (NASDAQ:CMPX)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Compass Therapeutics Charts.

Compass Therapeutics (NASDAQ:CMPX)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Compass Therapeutics Charts.

News Compass Therapeutics Inc

Compass Therapeutics to Participate in Upcoming Investor Events
Mittwoch 13 November 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 12 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update
Dienstag 12 November 2024 (2 Wochen vor) • GlobeNewswire Inc.

Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Freitag 8 November 2024 (3 Wochen vor) • GlobeNewswire Inc.

Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting
Freitag 4 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Montag 9 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Compass Therapeutics to Participate in Upcoming Investor Events
Dienstag 3 September 2024 (3 Monate vor) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Freitag 30 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 14 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 12 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 12 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update
Montag 12 August 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Compass Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen